XTS-002

N/A

Report date: 2026/02/27 20:01:47
NMEFirst In Class

Base Information

Drug NameXTS-002
Drug Alias NameXTS-002XTS002
ClassificationSmall molecules
Mechanisms of ActionNon-selective voltage-gated ion channel VDAC1 inhibitors
TargetsNon-selective voltage-gated ion channel VDAC1
Therapy Area/IndicationsAmyotrophic Lateral SclerosisParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesX-tosis Inc
China Registration ClassN/A

Develop Information

Active CompaniesX-tosis Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A